Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: .@US_FDA Drafts Guidance on Scientific and Ethical Considerations in Including Pregnant Women in #ClinicalTrials |… https://t.co/paiSHynavR
SteveFDA (R-D.C.)
@SGottliebFDA
RT @hdpalooza: FDA Commissioner, @SGottliebFDA will take the main stage at this year's #hdpalooza. Learn more:… https://t.co/f8dtBXj7lB
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: OCE Public Meeting April 20 on Relevant Molecular Targets in Pediatric Cancers #OCEPedsTargets https://t.co/fYIyJ7DjRY
SteveFDA (R-D.C.)
@SGottliebFDA
RT @ASCO: #ASCO18 speakers include legendary news journalist @tombrokaw, @NCIDirector, FDA Commissioner @SGottliebFDA, and AM… https://t.co/u07d207Z51
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA restricts sale of Essure device after becoming aware that some women were not being adequately informed of Essure’s risks before getting the device implanted; this is despite significant FDA efforts to educate patients and doctors about these risks:
SteveFDA (R-D.C.)
@SGottliebFDA
RT @megtirrell: FDA issues what it calls a "unique type of restriction" on sales of Bayer's Essure contraception device, to ensure… https://t.co/JoderIxkD7
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA issued guidance on including pregnant women in drug clinical trials, outlining scientific and ethical considerations for this important research to advance medical products for women; with patient safety in mind https://t.co/z2mhz21dK6 https://t.co/
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_MCMi: Healthcare professionals & students: Join @FDA_Drug_Info for an introductory webinar on drug safety surveillance &… https://t.co/tq7TLzi1l2
SteveFDA (R-D.C.)
@SGottliebFDA
We’re taking this first of its kind action to use certain post market authorities because we believe additional, meaningful safeguards are required to ensure women are able to make informed decisions about risk when considering Essure for birth control: h
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: The FDA will restrict sale and distribution of #Essure to protect women. The move will ensure that all women consid… https://t.co/QcftHwILS9
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk informatio… https://t.co/TAxilXLYTi
SteveFDA (R-D.C.)
@SGottliebFDA
RT @TedOkonCOA: Looking forward to #COA2018 — Community Oncology Conference outside of DC this Thursday/Friday. First up is keynote… https://t.co/vnFC7IBGpT
SteveFDA (R-D.C.)
@SGottliebFDA
RT @LizSzabo: C-SPAN: FDA Commissioner Scott Gottlieb Talks To KHN https://t.co/goNV7fynVq via @khnews
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA restricts sale of Essure device after becoming aware that some women were not being adequately informed of Ess… https://t.co/nvBlmLdIRZ
SteveFDA (R-D.C.)
@SGottliebFDA
3 more days until FDA’s #biosimilars @reddit AMA for #Pharmacists! The AMA opens up at 8AM ET for questions about the development and approval process, labeling, and more. https://t.co/weQtnpsjqZ https://t.co/flQEu7zPpr
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA took this first of its kind action to use certain post market authorities because we believe additional, meaningful safeguards are required to ensure women can make informed decisions about risk when considering Essure https://t.co/rlUo9QCRFm
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA restricts sale of Essure device after becoming aware some women were not being adequately informed of Essure’s risks before getting device implanted; despite significant FDA efforts to educate patients, doctors about these risks https://t.co/bGHbVlSM
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSGov: HHS @SecAzar held a strategic planning session on #opioids today with leaders from across HHS to discuss how to int… https://t.co/8fYSLuxHDe
SteveFDA (R-D.C.)
@SGottliebFDA
RT @fdalawblog: @SGottliebFDA Emerges as a Champion for Patient Engagement in 2018; Patient-Centric Guidance Development, Rare Dise… https://t.co/U1FOx5Rw18